awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38779793-0E29F37E-4DE7-4DA0-9BA2-D865C9A7739E
Q38779793-0E29F37E-4DE7-4DA0-9BA2-D865C9A7739E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38779793-0E29F37E-4DE7-4DA0-9BA2-D865C9A7739E
Evaluation of dosing strategy for pembrolizumab for oncology indications.
P2860
Q38779793-0E29F37E-4DE7-4DA0-9BA2-D865C9A7739E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38779793-0E29F37E-4DE7-4DA0-9BA2-D865C9A7739E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1b726f9ba6079651e552905a46810bc1ac903aa2
P2860
Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials.